Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (22)

2022

  1. A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

    Neuropsychiatric Disease and Treatment, Vol. 18, pp. 965-976

  2. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

2021

  1. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  2. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  3. Effectiveness of tianeptine in patients with m ajor depression and substance-related disorders

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 4, pp. 135-144

2020

  1. Professional perception of clozapine use in patients with dual psychosis

    Actas Espanolas de Psiquiatria, Vol. 48, Núm. 3, pp. 99-105

2019

  1. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 9, pp. 579-592

  2. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

    Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106

  3. Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients

    European Journal of Internal Medicine, Vol. 69, pp. 77-85

  4. The Big Data Sjögren consortium: A project for a new data science era

    Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23

2018

  1. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)

    Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111

  2. Latent impulsivity subtypes in substance use disorders and interactions with internalizing and externalizing co-occurring disorders

    Frontiers in Psychiatry, Vol. 9, Núm. FEB

2017

  1. Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

    Journal of Hematology and Oncology, Vol. 10, Núm. 1

  2. Treatment of comorbid alcohol dependence and anxiety disorder: Review of the scientific evidence and recommendations for treatment

    Frontiers in Psychiatry, Vol. 8, Núm. SEP

2016

  1. Diferencias relevantes en la percepción y el grado de conocimiento de los profesionales de las distintas Comunidades Autónomas españolas sobre la existencia de recursos para pacientes con patología dual

    Actas Espanolas de Psiquiatria, Vol. 44, Núm. 1, pp. 1-12

  2. Factores asociados a la incapacidad laboral temporal en peritajes psiquiátricos

    Actas Espanolas de Psiquiatria, Vol. 44, Núm. 4, pp. 119-124

  3. Professionals’ perception on the management of patients with dual disorders

    Patient Preference and Adherence, Vol. 10, pp. 1855-1868

  4. Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355

2014

  1. Dual diagnosis resource needs in Spain: A national survey of professionals

    Journal of Dual Diagnosis, Vol. 10, Núm. 2, pp. 84-90

  2. Professionals' perceptions about healthcare resources for co-occuring disorders in Spain

    International Journal of Mental Health Systems, Vol. 8, Núm. 1